HOME >> BIOLOGY >> NEWS
$1 million grant from Howard Hughes Medical Institute to fund joint neuroscience program

A $1 million, 3-year grant from the Howard Hughes Medical Institute (HHMI) awarded jointly to three prominent research universities all located in Newark, NJ will be used to develop a novel doctoral program designed to train future neuroscientists who can integrate approaches used in mathematics, biomedical sciences and computation as they investigate emerging questions in the neural sciences. The consortium of the New Jersey Institute of Technology (NJIT), Rutgers-Newark, and the University of Medicine and Dentistry of New Jersey (UMDNJ)-New Jersey Medical School was among 10 awardees selected from 132 applicants.

The inter-institutional quantitative neurosciences doctoral training program will be co-directed by Joshua Berlin of UMDNJ-New Jersey Medical School, Robert Miura of NJIT and James Tepper of Rutgers-Newark. It will employ state-of-the-art interdisciplinary approaches to explore and better explain the complex mechanisms underlying nerve and brain function.

"Although tremendous progress has been made in the neurosciences, daunting challenges remain," Tepper said. "The solutions to these problems are likely to be found by bringing together the tools and approaches from many different disciplines. The HHMI award will allow us to train a new generation of scientists who can work at the interface of quantitative, computational and biological science to address these problems."

Miura said that by working together, the three universities will be able to create a particularly effective doctoral program. "The HHMI training grant represents a significant new opportunity to take advantage of the myriad complementary strengths of the faculty of UMDNJ-New Jersey Medical School, Rutgers-Newark and NJIT," he noted. "With their physical proximity and close ties among the faculty, these three institutions will create a unique environment unparalleled in interdisciplinary neuroscience training."

Berlin agreed. "The HHMI program
'"/>

Contact: Sheryl Weinstein
sheryl.m.weinstein@njit.edu
973-596-3436
New Jersey Institute of Technology
22-Nov-2005


Page: 1 2 3

Related biology news :

1. US Department of Defense awards $1.6 million for implantable biochip research
2. Nottingham biosciences million pound injection
3. $9 million EPSCoR grant to foster integrated research
4. 20 Kentucky firms share $1.9 million from state to match federal SBIR-STTR awards
5. $125 million bioenergy initiative powered by Midwest ag industry, MSU research
6. UC Davis is partner in new $125 million federal bioenergy research center
7. Energy department selects 3 Bioenergy Research Centers for $375 million in federal funding
8. The BBVA Foundation commits 2.4 million euros to research in Ecology and Conservation Biology
9. New $1.16 million study investigates how dietary iron is used by cells
10. 5.9 million award gives UK aging research a new lease on life
11. NIH awards nearly $21 million to fund cutting-edge research equipment

Post Your Comments:
(Date:8/6/2015)... 6, 2015  Today, U.S. Congressman Mike ... ™ to learn firsthand how Silicon Valley technologies ... is a world leader in multi-factor identity management ... helping federal agencies and commercial organizations achieve new ... "The vast majority of network breaches can ...
(Date:8/5/2015)... ALBANY, New York , August 5, 2015 /PRNewswire/ ... new market report titled "Facial Recognition Market - Global ... - 2022", the global market for facial recognition is ... market is driven by increased demand for surveillance systems ... to the rising number of crimes and terrorist activities ...
(Date:8/3/2015)... 2015 Synaptics, Inc. (Nasdaq: SYNA ), ... that members of the executive management team will present ... Technology Leadership Forum on Tuesday, August 11, 2015 at ... at the Sonnenalp Resort in Vail, CO. ... forward-looking information. An audio webcast of the event will ...
Breaking Biology News(10 mins):Rep. Honda to Visit Crossmatch in Redwood City 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 4Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 5Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 6
(Date:8/27/2015)... , Aug. 27, 2015 /PRNewswire/ - Portage Biotech ... PBT.U), and Biohaven Pharmaceutical Holding Company Limited (Biohaven), ... Phase I study of BHV-0223, a glutamate modulating ... regarding BHV-0223 and recently obtained clearance from the ... with human testing. Portage holds 54% equity interest ...
(Date:8/27/2015)... , August 27, 2015 GlassesOff ... image processing functions in the human vision system, announced today ... point guard Chris Paul to develop a ... who want to improve their real-life on-court performance. ... court, whether it is shooting a ball or blocking a ...
(Date:8/26/2015)... ... August 26, 2015 , ... MediVet ... a second US laboratory is to open in Manhattan, Kansas in early October, ... and long-term growth of research and development through collaboration with researchers from Kansas ...
(Date:8/26/2015)... 26, 2015  Platform therapeutic company Symic Biomedical, ... a $1.5M Phase II SBIR grant from the ... its therapeutic agent to reduce arteriovenous fistula (AVF) ... stage renal disease (ESRD) patients undergoing hemodialysis. The ... Diabetes and Digestive and Kidney Diseases (NIDDK), will ...
Breaking Biology Technology:Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 2Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 3MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 2MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 3Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3
Cached News: